A randomized controlled trial performed in nondiabetic subjects with morbid obesity and severe obstructive sleep apnea found that the effective treatment of OSA with continuous positive airway pressure (CPAP) therapy for 12 weeks improves glucose tolerance without improvement in insulin resistance. According to the authors, the results support the use of CPAP as an adjunct therapy to lifestyle intervention in order to improve glucose metabolism in individuals with morbid obesity and severe sleep apnea. Study results are published in the January issue of SLEEP.
Read the study in SLEEP: A Randomized Controlled Trial of Continuous Positive Airway Pressure on Glucose Tolerance in Obese Patients with Obstructive Sleep Apnea
